1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Anna Palmer
Our people

Anna Palmer

Honorary Associate

anna.palmer@honorary.burnet.edu.au
Anna Palmer

Background

Anna completed her Bachelor of Biomedical Science (Honours) at the Burnet in 2016, researching crystal methamphetamine use amongst people who inject drugs.

In 2019, she completed a Master of Mathematical Sciences (Advanced) at the Australian National University, with a focus on applied mathematics and mathematical modelling of infectious diseases.

Anna now works as a research assistant at Burnet Institute in the Modelling and Biostatistics working group. She works on a variety of mathematical modelling/health economics projects related to injecting drug use and hepatitis C elimination.

She intends to continue her career developing mathematical models in public health.

Qualifications

  • 2019: Master of Mathematical Sciences (Advanced), The Australian National University, Australia
  • 2016: Bachelor of Biomedical Science (Honours), Monash University, Australia
  • 2015: Bachelor of Biomedicine, University of Melbourne, Australia

Burnet publications

View 23 more
20 Oct 2023

Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar

JGH Open

Bridget Draper, Anna Palmer, Margaret Hellard, Nick Scott

Open access
25 Jan 2023

Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts

Scientific Reports

Tom Walsh, Farah Houdroge, Anna Palmer, Dominic Delport, Sherrie L. Kelly, Samuel Hainsworth, Romesh Abeysuriya, Farah Houdroge, Anna Palmer, Dominic Delport

Open access
25 Jan 2023

Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts

Scientific Reports

Tom Walsh, Farah Houdroge, Anna Palmer, Dominic Delport, Sherrie L. Kelly, Samuel Hainsworth, Romesh Abeysuriya, Farah Houdroge, Anna Palmer, Dominic Delport

Open access

Current projects

Hepatitis C modelling

Hepatitis C modelling

Our modelling aims to help countries identify the most effective and cost-effective ways to eliminate hepatitis C as a public health threat.

Past projects

The elimination of hepatitis C as a global public health threat

The elimination of hepatitis C as a global public health threat

This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

Eliminate C (EC) Victoria partnership

Eliminate C (EC) Victoria partnership

A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.

On this page